EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update
Ann Rheum Dis 2025;0:1−16 Doi: 10.1016/j.ard.2025.09.007
The updated EULAR recommendations provide evidence- and expert-based consensus on the management of SLE with kidney involvement, adjusted for severity, and taking into consideration long-term efficacy, safety, cost, and local availability of drugs. Fanouriakis A et al. updated the 2019 EULAR/ ERA-EDTA recommendations for the management of SLE with kidney involvement, taking into consideration emerging evidence and recent developments in the field.
Following the 2019 EULAR recommendations for the management of general SLE, authors created a list of quality indicators; these were validated both internally, as well as independently in a cohort of patients in relation to their quality of life. Authors have updated the EULAR recommendations for SLE with kidney involvement, in view of significant recent advances, to provide physicians with evidence- and eminence-based guidance.
Keywords:
